UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.913

Sortiert nach

Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid

British journal of pharmacology, 2007-05, Vol.151 (1), p.142-151

2007

Volltextzugriff (PDF)

Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity

Oncogene, 2009-10, Vol.28 (43), p.3837-3846

2009

Volltextzugriff (PDF)

Isolation, identification and biological activity of gastrin-releasing peptide 1–46 (oGRP 1–46), the primary GRP gene-derived peptide product of the pregnant ovine endometrium

Peptides (New York, N.Y. : 1980), 2010-02, Vol.31 (2), p.284-290

2010

Volltextzugriff (PDF)

Indomethacin reduces lung adenoma number in A/J mice

Anticancer research, 2001-05, Vol.21 (3B), p.1749

2001

Volltextzugriff (PDF)

Effects of acute restraint stress on endogenous adrenomedullin levels

Neuroreport, 1999-09, Vol.10 (13), p.2829-2833

1999

Volltextzugriff (PDF)

VIP-ellipticine derivatives inhibit the growth of breast cancer cells

Life sciences (1973), 2002-07, Vol.71 (9), p.1005-1014

2002

Volltextzugriff (PDF)

Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells

Oncogene, 2004-08, Vol.23 (36), p.6170-6174

2004

Volltextzugriff (PDF)

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs

Anticancer research, 1998-03, Vol.18 (2A), p.775

1998

Volltextzugriff (PDF)

A Vasoactive Intestinal Peptide Antagonist Inhibits Non-Small Cell Lung Cancer Growth

Proceedings of the National Academy of Sciences - PNAS, 1993-05, Vol.90 (10), p.4345-4349

1993

Volltextzugriff (PDF)

An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system

The Journal of pharmacology and experimental therapeutics, 1991-06, Vol.257 (3), p.959

1991

Volltextzugriff (PDF)

Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes

American journal of obstetrics and gynecology, 1996-10, Vol.175 (4), p.906-911

1996

Volltextzugriff (PDF)

Sigma ligands inhibit the growth of small cell lung cancer cells

Life sciences (1973), 2000-04, Vol.66 (20), p.1979-1986

2000

Volltextzugriff (PDF)

Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist

Cancer research (Chicago, Ill.), 1996-08, Vol.56 (15), p.3486-3489

1996

Volltextzugriff (PDF)

VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells

Breast cancer research and treatment, 2001-07, Vol.68 (1), p.55-64

2001

Volltextzugriff (PDF)

Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications

Peptides, 2004-03, Vol.25 (3), p.511-520

2004

Volltextzugriff (PDF)

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

Nature (London), 1985-08, Vol.316 (6031), p.823-826

1985

Volltextzugriff (PDF)

PACAP(6–38) inhibits the growth of prostate cancer cells

Cancer letters, 1998-03, Vol.125 (1), p.131-139

1998

Volltextzugriff (PDF)

Growth factor and peptide receptors in small cell lung cancer

Life Sciences, 1993, Vol.52 (14), p.1161-1173

1993

Volltextzugriff (PDF)

Blockade of brain bombesin/GRP receptors increases food intake in satiated rats

American journal of physiology. Regulatory, integrative and comparative physiology, 1993-05, Vol.264 (5), p.1031-R1034

1993

Volltextzugriff (PDF)

Neuromedin B is present in lung cancer cell lines

Cancer research (Baltimore), 1992-05, Vol.52 (9), p.2732s-3736s

1992

Volltextzugriff (PDF)

Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines

The Journal of pharmacology and experimental therapeutics, 1992-10, Vol.263 (1), p.311

1992

Volltextzugriff (PDF)

HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates

Brain research, 1993-02, Vol.603 (2), p.222-233

1993

Volltextzugriff (PDF)

Neuropeptides as autocrine growth factors in cancer cells

Current pharmaceutical design, 2003-01, Vol.9 (6), p.495

2003

Volltextzugriff (PDF)

Establishment and identification of small cell lung cancer cell lines having classic and variant features

Cancer research (Chicago, Ill.), 1985-06, Vol.45 (6), p.2913-2923

1985

Volltextzugriff (PDF)

The metabolism of BW2258U89, a GRP receptor antagonist

Neuropeptides (Edinburgh), 2000-04, Vol.34 (2), p.108-115

2000

Volltextzugriff (PDF)

1 – 25 von 2.913

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.282)
Mit Volltextzugriff
(2.449)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.676)
Life Sciences & Biomedicine
(1.082)
Humans
(693)
Biological And Medical Sciences
(514)
Animals
(509)
Physical Sciences
(421)
Male
(380)
Female
(356)
Medical Sciences
(288)
Technology
(272)
Fundamental And Applied Biological Sciences. Psychology
(243)
Physics
(231)
Adult
(166)
Biochemistry & Molecular Biology
(157)
Chemistry
(148)
Neurosciences & Neurology
(134)
Pharmacology & Pharmacy
(134)
Middle Aged
(133)
Exact Sciences And Technology
(132)
Rats
(132)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid

Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity

Isolation, identification and biological activity of gastrin-releasing peptide 1–46 (oGRP 1–46), the primary GRP gene-derived peptide product of the pregnant ovine endometrium

Indomethacin reduces lung adenoma number in A/J mice

Effects of acute restraint stress on endogenous adrenomedullin levels

VIP-ellipticine derivatives inhibit the growth of breast cancer cells

Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs

A Vasoactive Intestinal Peptide Antagonist Inhibits Non-Small Cell Lung Cancer Growth

An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system

Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes

Sigma ligands inhibit the growth of small cell lung cancer cells

Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist

VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells

Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

PACAP(6–38) inhibits the growth of prostate cancer cells

Growth factor and peptide receptors in small cell lung cancer

Blockade of brain bombesin/GRP receptors increases food intake in satiated rats

Neuromedin B is present in lung cancer cell lines

Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines

HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates

Neuropeptides as autocrine growth factors in cancer cells

Establishment and identification of small cell lung cancer cell lines having classic and variant features

The metabolism of BW2258U89, a GRP receptor antagonist

Suchergebnisse filtern